Clinical Trials Directory

Trials / Completed

CompletedNCT01946750

Predictive Value of the Immune Response of the Host in Clostridium Difficile Infections

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
240 (actual)
Sponsor
Versailles Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Hypothesis: the antibody directed against certain antigens of Clostridium difficile would be predict the Clostridium difficile infection. This study evaluates the weight of immunity by studying patients with Clostridium difficile infection versus controls (each patient is associated with two controls : diarrheal control without Clostridium difficile, and non-diarrheal control with or without Clostridium difficile). Recurrence and the kinetics of immune response following infection Clostridium difficile are studied by following the patients during three months. There are also building biological samples collections clinically documented: sera, stool and strains.

Conditions

Interventions

TypeNameDescription
BIOLOGICALSerum
BIOLOGICALStools
BIOLOGICALSalivaOptional sample collected for the cases and non-diarrheal control at the same time as the serum, to compare the presence of specific salivary Immune globulin type A (IgA) of C. difficile antibodies than in the serum.
BIOLOGICALWhole bloodOptional sample collected for the cases and non-diarrheal control at the same time as the serum, in order to study cellular immunity and describe the determinants of the development of a protective adaptive response.

Timeline

Start date
2012-12-01
Primary completion
2016-06-01
Completion
2017-06-01
First posted
2013-09-20
Last updated
2017-08-22

Locations

24 sites across 1 country: France

Source: ClinicalTrials.gov record NCT01946750. Inclusion in this directory is not an endorsement.